The site will bolster the firm’s capabilities in pharma and consumer healthcare manufacturing capacity and will allow Formulated Solutions to bring additional production capacity online
The entrance to 455,000 square foot Cleveland, TN pharma production site. (Credit: PR Newswire/ Formulated Solutions)
US-based Formulated Solutions has signed a new deal to acquire a 455,000ft² FDA-approved pharmaceutical liquids, semi-solids, aerosol, BoV, and metered dose nasal spray production facility located in Tennessee, US.
Established in 1999, Formulated Solutions is a contract development and manufacturing organisation (CDMO).
The addition of the new site in Cleveland will bolster the firm’s capabilities in topicals, metered dose nasal sprays, and the pressurised package manufacturing sector.
Additionally, the plant will allow the firm to quickly bring additional production capacity online and support the growth of its future product pipeline.
Formulated Solutions said that the Cleveland facility has broad capabilities for producing and packaging pharmaceutical and consumer self-care formulations.
Located on a 60-acre site, the two-building facility has seen many capital improvements over the past five years. It now has a wide range of product capabilities, including the ability to blend liquids, semi-solids, and suspensions.
It also has packaging capabilities that range from flexible tubes, liquid-fill bottles, and metered dose sprays to traditional aerosol and bag-on-valve aerosol delivery systems.
The site was previously been owned and run by several different pharmaceutical corporations. This will be the first time in the site’s 43-year history that a privately held CDMO will be in charge of running it.
Formulated Solutions chief operating officer John Maddox said: “With an average year over year growth of well over 50% annually.
“Formulated Solutions is thrilled to add the aerosol, bag-on-valve, and liquid-fill capabilities of this 455,000ft² site to our manufacturing assets.
“Our customers, consumers, physicians, and patients rely on us each and every day to supply high quality, cost-effective solutions for consumer self-care and physician-advised treatments.
“This acquisition will help us further fulfil that commitment to all our marketing partners as our business continues to grow and evolve.”